Badania własne


Współwystępowanie chorób neuroimmunologicznych i cukrzycy.
Medycyna po Dyplomie, wydanie specjalne 2007, supl. 3/07, 75 – 80.
Index Copernicus =2,33

Stężenia leptyny w surowicy a insulinooporność u chorych na stwardnienie rozsiane.
Serum leptin concentrations as related to insulin resistance in multiple sclerosis patients.
Neurol. Neurochir. Pol. 2008 T. 42 nr 4 supl. 4 s. S494-S495.
XX Zjazd Polskiego Towarzystwa Neurologicznego. Wrocław, 3-6 września 2008 r

Serum leptin, soluble leptin receptor and ghrelin in multiple sclerosis and myasthenic patients.
Neurology 2008, 70 (11), supl.1, A331
IF : 5,69

Beta-cells specific antibodies in neurological autoimmune disorders.
Acta NeurobiolExp 2006, 66 (4), 407
IF = 1,209
Index Copernicus =18,82
MNiI = 10

Insulin resistance in multiple sclerosis patients after steroid treatment.
J Neural Transmission 2007, 114 (7), CXXX
IF = 2.938

Corticosteroid therapy has an effect on insulin resistance in nondiabetic multiple sclerosis patients, while remains neutral in myasthenia gravis subjects.
2nd International Congress on Prediabetes and the metabolic syndrome, Barcelona April 25– 28, 2007
Diabetes & Vascular Disease Research 2007, 4 (supl. 1), 157

Anti-GAD and IA-2 antibodies in neuroimmunological diseases.
Neuroforum 2007, 1 (XIII), T35-11C

Methylprednisolone reduces serum RAGE in multiple sclerosis patients during relapse.
3rd Congress on Prediabetes and Metabolic Syndrome, Nice 1-4 April 2009

Wykładniki insulinooporności a stężenie RAGE w surowicach chorych na stwardnienie rozsiane.
Endokr. Otyłość 2009 T. 5 nr 3 s. 160.
II Zjazd Polskiego Towarzystwa Badań nad Otylością. Szczecin, 15-17 X 2009

The effect of methylprednisolone, interferon beta and glatiramer acetate treatment in circulating adipokines in multiple sclerosis patients.
Neurology 2011 Vol. 76 nr 9 suppl. 4 s. A598-A599.
63rd AAN Annual Meeting. April 2-16, 2011, Hawaii, Honolulu.

Serum resistin levels are reduced by immunomodulatory treatment of relapting-remitting multiple sclerosis.
Clin. Chem. Lab. Med. 2011 Vol. 49 suppl. 1 s. S623.
IFCC-WorldLab-EuroMedLab Berlin 2011. 21st International Congress of Clinical Chemistry and Laboratory
Medicine. 19th IFCC-EFCC European Congress of Clinical Chemistry and Laboratory Medicine.
8th Annual Meeting of the German Society of Clinical Chemistry and Laboratory Medicine. Berlin, Germany, 15-19 May 2011.

Interleukin 17 receptor in multiple sclerosis patients treated with interferon β-1a.
Folia Neuropathol. 2011 Vol. 49 nr 2 s. 138-141 tab. bibliogr. abstr.
IF 1.234
Punktacja KBN/MNiI: 20.000

Interleukin-17 receptor in multiple sclerosis patients treated by interferon B-1A.
Acta Clin. Croat. 2011 Vol. 50 suppl. 2 s. 102.
The 51st International Neuropsychiatric Pula Congress, June 15-18, 2011, Pula, Croatia.